Abnormalities in tests of copper metabolism in primary sclerosing cholangitis

John B. Gross, Jurgen Ludwig, Russell H. Wiesner, John T. McCall, Nicholas F La Russo

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Primary sclerosing cholangitis is a chronic, cholestatic syndrome characterized by fibrosing inflammation of the bile ducts that may lead to cirrhosis and death from liver failure. Previous reports have suggested abnormal hepatic copper metabolism in this disease. Therefore, in 70 patients, we prospectively determined the levels of hepatic copper, serum copper, and serum ceruloplasmin, and the rate of urinary copper excretion to assess the diagnostic and prognostic usefulness of these tests. Virtually all patients had at least one abnormal copper test. Hepatic copper levels were elevated in 87% of patients [292 ± 38 μg/g dry wt (mean ± SE)] and 24-h urinary copper levels in 64% of patients [135 ± 15 μg/24 h (mean ± SE)] to values comparable to those seen in Wilson's disease or primary biliary cirrhosis. In advanced histologic stages of primary sclerosing cholangitis, progressively higher mean levels of hepatic and urinary copper were found. In the liver, mean copper content (in micrograms per gram dry weight) in disease stages I and II was 147 ± 36 (mean ± SE); in stage III (fibrosis), 302 ± 68; and in stage IV (cirrhosis), 379 ± 69. In the urine, mean copper excretion (in micrograms per 24 h) in stages I and II was 72 ± 14 (mean ± SE); in stage III, 100 ± 14; and in stage IV, 207 ± 30. Higher hepatic and urinary copper levels at initial evaluation were associated with decreased survival during a median follow-up period of 2.6 yr: patients with hepatic copper > 250 μg/g dry wt and urinary copper excretion > 200 μg/ 24 h at initial evaluation had an 18-mo survival of <60%. We conclude that abnormal copper metabolism is a universal feature of primary sclerosing cholangitis, that hepatic copper accumulates and urinary copper excretion increases as the disease progresses, and that the hepatic copper concentration and the 24-h urinary copper determination are useful prognostic indicators in this disease.

Original languageEnglish (US)
Pages (from-to)272-278
Number of pages7
JournalGastroenterology
Volume89
Issue number2
StatePublished - 1985

Fingerprint

Sclerosing Cholangitis
Copper
Liver
Fibrosis
Hepatolenticular Degeneration
Ceruloplasmin
Survival
Biliary Liver Cirrhosis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Gross, J. B., Ludwig, J., Wiesner, R. H., McCall, J. T., & La Russo, N. F. (1985). Abnormalities in tests of copper metabolism in primary sclerosing cholangitis. Gastroenterology, 89(2), 272-278.

Abnormalities in tests of copper metabolism in primary sclerosing cholangitis. / Gross, John B.; Ludwig, Jurgen; Wiesner, Russell H.; McCall, John T.; La Russo, Nicholas F.

In: Gastroenterology, Vol. 89, No. 2, 1985, p. 272-278.

Research output: Contribution to journalArticle

Gross, JB, Ludwig, J, Wiesner, RH, McCall, JT & La Russo, NF 1985, 'Abnormalities in tests of copper metabolism in primary sclerosing cholangitis', Gastroenterology, vol. 89, no. 2, pp. 272-278.
Gross, John B. ; Ludwig, Jurgen ; Wiesner, Russell H. ; McCall, John T. ; La Russo, Nicholas F. / Abnormalities in tests of copper metabolism in primary sclerosing cholangitis. In: Gastroenterology. 1985 ; Vol. 89, No. 2. pp. 272-278.
@article{c6828e4b7d614d5c9f8fc6824558474c,
title = "Abnormalities in tests of copper metabolism in primary sclerosing cholangitis",
abstract = "Primary sclerosing cholangitis is a chronic, cholestatic syndrome characterized by fibrosing inflammation of the bile ducts that may lead to cirrhosis and death from liver failure. Previous reports have suggested abnormal hepatic copper metabolism in this disease. Therefore, in 70 patients, we prospectively determined the levels of hepatic copper, serum copper, and serum ceruloplasmin, and the rate of urinary copper excretion to assess the diagnostic and prognostic usefulness of these tests. Virtually all patients had at least one abnormal copper test. Hepatic copper levels were elevated in 87{\%} of patients [292 ± 38 μg/g dry wt (mean ± SE)] and 24-h urinary copper levels in 64{\%} of patients [135 ± 15 μg/24 h (mean ± SE)] to values comparable to those seen in Wilson's disease or primary biliary cirrhosis. In advanced histologic stages of primary sclerosing cholangitis, progressively higher mean levels of hepatic and urinary copper were found. In the liver, mean copper content (in micrograms per gram dry weight) in disease stages I and II was 147 ± 36 (mean ± SE); in stage III (fibrosis), 302 ± 68; and in stage IV (cirrhosis), 379 ± 69. In the urine, mean copper excretion (in micrograms per 24 h) in stages I and II was 72 ± 14 (mean ± SE); in stage III, 100 ± 14; and in stage IV, 207 ± 30. Higher hepatic and urinary copper levels at initial evaluation were associated with decreased survival during a median follow-up period of 2.6 yr: patients with hepatic copper > 250 μg/g dry wt and urinary copper excretion > 200 μg/ 24 h at initial evaluation had an 18-mo survival of <60{\%}. We conclude that abnormal copper metabolism is a universal feature of primary sclerosing cholangitis, that hepatic copper accumulates and urinary copper excretion increases as the disease progresses, and that the hepatic copper concentration and the 24-h urinary copper determination are useful prognostic indicators in this disease.",
author = "Gross, {John B.} and Jurgen Ludwig and Wiesner, {Russell H.} and McCall, {John T.} and {La Russo}, {Nicholas F}",
year = "1985",
language = "English (US)",
volume = "89",
pages = "272--278",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Abnormalities in tests of copper metabolism in primary sclerosing cholangitis

AU - Gross, John B.

AU - Ludwig, Jurgen

AU - Wiesner, Russell H.

AU - McCall, John T.

AU - La Russo, Nicholas F

PY - 1985

Y1 - 1985

N2 - Primary sclerosing cholangitis is a chronic, cholestatic syndrome characterized by fibrosing inflammation of the bile ducts that may lead to cirrhosis and death from liver failure. Previous reports have suggested abnormal hepatic copper metabolism in this disease. Therefore, in 70 patients, we prospectively determined the levels of hepatic copper, serum copper, and serum ceruloplasmin, and the rate of urinary copper excretion to assess the diagnostic and prognostic usefulness of these tests. Virtually all patients had at least one abnormal copper test. Hepatic copper levels were elevated in 87% of patients [292 ± 38 μg/g dry wt (mean ± SE)] and 24-h urinary copper levels in 64% of patients [135 ± 15 μg/24 h (mean ± SE)] to values comparable to those seen in Wilson's disease or primary biliary cirrhosis. In advanced histologic stages of primary sclerosing cholangitis, progressively higher mean levels of hepatic and urinary copper were found. In the liver, mean copper content (in micrograms per gram dry weight) in disease stages I and II was 147 ± 36 (mean ± SE); in stage III (fibrosis), 302 ± 68; and in stage IV (cirrhosis), 379 ± 69. In the urine, mean copper excretion (in micrograms per 24 h) in stages I and II was 72 ± 14 (mean ± SE); in stage III, 100 ± 14; and in stage IV, 207 ± 30. Higher hepatic and urinary copper levels at initial evaluation were associated with decreased survival during a median follow-up period of 2.6 yr: patients with hepatic copper > 250 μg/g dry wt and urinary copper excretion > 200 μg/ 24 h at initial evaluation had an 18-mo survival of <60%. We conclude that abnormal copper metabolism is a universal feature of primary sclerosing cholangitis, that hepatic copper accumulates and urinary copper excretion increases as the disease progresses, and that the hepatic copper concentration and the 24-h urinary copper determination are useful prognostic indicators in this disease.

AB - Primary sclerosing cholangitis is a chronic, cholestatic syndrome characterized by fibrosing inflammation of the bile ducts that may lead to cirrhosis and death from liver failure. Previous reports have suggested abnormal hepatic copper metabolism in this disease. Therefore, in 70 patients, we prospectively determined the levels of hepatic copper, serum copper, and serum ceruloplasmin, and the rate of urinary copper excretion to assess the diagnostic and prognostic usefulness of these tests. Virtually all patients had at least one abnormal copper test. Hepatic copper levels were elevated in 87% of patients [292 ± 38 μg/g dry wt (mean ± SE)] and 24-h urinary copper levels in 64% of patients [135 ± 15 μg/24 h (mean ± SE)] to values comparable to those seen in Wilson's disease or primary biliary cirrhosis. In advanced histologic stages of primary sclerosing cholangitis, progressively higher mean levels of hepatic and urinary copper were found. In the liver, mean copper content (in micrograms per gram dry weight) in disease stages I and II was 147 ± 36 (mean ± SE); in stage III (fibrosis), 302 ± 68; and in stage IV (cirrhosis), 379 ± 69. In the urine, mean copper excretion (in micrograms per 24 h) in stages I and II was 72 ± 14 (mean ± SE); in stage III, 100 ± 14; and in stage IV, 207 ± 30. Higher hepatic and urinary copper levels at initial evaluation were associated with decreased survival during a median follow-up period of 2.6 yr: patients with hepatic copper > 250 μg/g dry wt and urinary copper excretion > 200 μg/ 24 h at initial evaluation had an 18-mo survival of <60%. We conclude that abnormal copper metabolism is a universal feature of primary sclerosing cholangitis, that hepatic copper accumulates and urinary copper excretion increases as the disease progresses, and that the hepatic copper concentration and the 24-h urinary copper determination are useful prognostic indicators in this disease.

UR - http://www.scopus.com/inward/record.url?scp=0021796418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021796418&partnerID=8YFLogxK

M3 - Article

C2 - 4007418

AN - SCOPUS:0021796418

VL - 89

SP - 272

EP - 278

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 2

ER -